Impact of Diabetic Retinal Disease on Patients’ Lives: Listening to the Healthcare Experts

Join us for a highly interactive virtual meeting of global healthcare experts interested in medical product innovation and adoption. The aims of this pilot deployment of a first-in-class AI platform, called “NATTER”, is to better understand the barriers to eliminating vision loss from diabetic retinal disease (DRD).

With an emphasis on building consensus around useful biomarkers and endpoints needed to accelerate the development of devices, biologics, and drugs for the prevention and cure of vision loss from DRD, we will undertake a novel approach to capture and analyze participant feedback in a series of one-on-one conversations centered on responses to key questions. Global experts will include clinicians, academic scientists, pharma industry scientists, clinical trial experts (CRO), regulatory consultants, payors, and systems of care innovators.